| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |